Our Pricing

Wegovy UK Pricing: Private Prescription from £79.00

Published on: June 03, 2026

Searching for transparent wegovy uk price private prescription information? At Cured Pharmacy, Wegovy (semaglutide) is available from £79.00 with a private prescription, following a free online consultation with UK-registered prescribers. Our upfront pricing model ensures you know the exact cost before starting your clinical assessment.

Understanding Wegovy UK Price Private Prescription Options

Wegovy is a prescription-only medication in the UK, licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. Private prescriptions offer faster access compared to NHS pathways, which currently have limited availability due to supply prioritisation.

At Cured Pharmacy, Wegovy pricing starts from £79.00 per pen, with the final cost determined by your prescribed dose following clinical assessment. Our UK-registered prescribers evaluate your medical history, current medications, and weight management goals during a consultation that typically takes under three minutes to complete.

The private prescription route includes the cost of your medication, clinical consultation with a UK prescriber, and discreet home delivery. Unlike some providers, we display pricing transparently before you begin your assessment, ensuring no hidden fees or unexpected charges at checkout.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone involved in appetite regulation and glucose metabolism [2]. By activating GLP-1 receptors in the brain, semaglutide reduces hunger signals, increases feelings of fullness after meals, and slows gastric emptying.

In the landmark STEP 1 clinical trial, participants using Wegovy alongside lifestyle modifications achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group [2]. These results demonstrated that semaglutide produces clinically significant weight loss when combined with a reduced-calorie diet and increased physical activity.

Wegovy is administered as a once-weekly subcutaneous injection using a pre-filled pen. Treatment begins at a low dose of 0.25 mg weekly, gradually escalating over 16-20 weeks to the maintenance dose of 2.4 mg weekly. This dose titration approach minimises gastrointestinal side effects whilst allowing your body to adjust to the medication [1].

Expected Results and Timeline

Most patients begin noticing appetite reduction within the first 2-4 weeks of starting Wegovy, though significant weight loss typically becomes apparent after 12-16 weeks at therapeutic doses. Clinical trials showed that the majority of weight loss occurred within the first 60 weeks of treatment, with weight maintenance thereafter [2].

Your UK prescriber will monitor your progress and may adjust your treatment plan based on your response. It's important to note that individual results vary, and Wegovy works best as part of a comprehensive weight management programme including dietary changes and regular physical activity.

Wegovy vs Mounjaro: Comparing Weight Loss Injections

Both Wegovy and Mounjaro are once-weekly injectable medications licensed in the UK for weight management, but they work through different mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist available [3].

In head-to-head clinical trials (SURPASS-2), tirzepatide demonstrated superior weight loss compared to semaglutide, with patients on the highest tirzepatide dose achieving up to 22.5% body weight reduction versus 15.8% with semaglutide 1.0 mg [3]. However, both medications produce clinically meaningful weight loss when used as prescribed.

The choice between Wegovy and Mounjaro depends on several factors including your medical history, previous treatment response, side effect profile, and budget considerations. Mounjaro typically represents a higher initial investment, whilst Wegovy offers competitive pricing with an established safety profile backed by extensive real-world use.

Which Treatment Is Right for You?

Your UK prescriber will assess your individual circumstances during the online consultation, considering factors such as your BMI, weight loss goals, existing medical conditions, and current medications. Some patients may be better suited to one treatment over another based on contraindications or previous tolerance to GLP-1 medications.

Both treatments require commitment to lifestyle modifications for optimal results. Your prescriber can provide guidance on dietary approaches, physical activity recommendations, and strategies to manage potential side effects during the initial titration phase.

Wegovy Pricing UK: What Affects the Cost?

Several factors influence the overall cost of Wegovy treatment through private prescription. The prescribed dose is the primary determinant—patients starting at lower doses during titration will have different costs compared to those on the maintenance dose of 2.4 mg weekly.

At Cured Pharmacy, our pricing structure is transparent and competitive. Wegovy is available from £79.00, with no additional consultation fees or hidden charges. This contrasts with some providers who charge separately for prescriber assessments, follow-up consultations, or subscription models with cancellation fees.

Treatment duration also impacts total cost. Most patients require at least 6-12 months of continuous treatment to achieve and maintain significant weight loss, as demonstrated in clinical trials [2]. Your prescriber will discuss realistic timelines during your consultation and can advise on the expected duration based on your weight management goals.

Alternative Weight Loss Treatments Available

Beyond Wegovy and Mounjaro, several other prescription weight loss medications are available through Cured Pharmacy. Saxenda (liraglutide) is a daily GLP-1 injection that has been available longer than weekly alternatives, offering an established safety profile for patients who prefer daily dosing or have previously used liraglutide successfully.

Orlistat-based treatments including Xenical, Alli, and Orlos work through a completely different mechanism—blocking fat absorption in the digestive system rather than affecting appetite hormones [4]. These oral medications may suit patients who prefer tablets over injections or have contraindications to GLP-1 receptor agonists.

Mysimba (naltrexone/bupropion combination) represents another oral option, working on brain pathways that control appetite and reward responses [5]. Each treatment has distinct advantages, side effect profiles, and suitability criteria that your UK prescriber will evaluate during your clinical assessment.

Choosing Between Injectable and Oral Treatments

Injectable GLP-1 medications like Wegovy and Mounjaro generally produce greater weight loss in clinical trials compared to oral alternatives, but they require comfort with self-injection and may cause more gastrointestinal side effects initially [2][3][4]. Oral medications offer convenience and familiarity but typically result in more modest weight reduction.

Your medical history, lifestyle preferences, and previous treatment experiences all influence which option is most appropriate. Our UK prescribers take a personalised approach, ensuring the recommended treatment aligns with your individual circumstances and weight management objectives.

How to Order Wegovy from Cured Pharmacy

Ordering Wegovy through Cured Pharmacy is straightforward and completed entirely online. Begin by starting the free medical consultation through our secure platform, where you'll answer questions about your medical history, current health status, medications, and weight loss goals. This assessment typically takes under three minutes to complete.

A UK-registered prescriber from our clinical team, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), will review your consultation within hours. If Wegovy is deemed clinically appropriate and safe for you, a private prescription will be issued and your medication dispensed from our GPhC-registered pharmacy (9012511).

Your Wegovy pens are dispatched in 100% discreet packaging with next-day delivery options available. All orders include patient information leaflets, injection technique guidance, and access to our pharmacy team for any questions about your treatment. Follow-up consultations can be arranged as needed to monitor your progress and adjust treatment if required.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
5. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595–605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss medications work best when combined with lifestyle modifications including diet and exercise.